Teddi Mellencamp refuses famous father’s plea to move home to Indiana during cancer fightTeddi Mellencamp refuses famous father’s plea to move home to Indiana during cancer fight
“Real Housewives” star and “The Masked Singer” contestant Teddi Mellencamp opens up about her stage four melanoma recovery and why she won’t leave LA despite her famous father’s wishes.
STAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of WegovySTAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy
The Department of Health and Human Services asked the Department of Justice to investigate Hims & Hers for potentially violating federal law over its plan to make a compounded version of a low-cost weight loss pill widely available on its telehealth platform, according to a social media post by HHS general counsel Mike Stuart. The Read More
3D-Printed Breast Tissue; Cancer and Ultraprocessed Food; Agent Orange and Melanoma3D-Printed Breast Tissue; Cancer and Ultraprocessed Food; Agent Orange and Melanoma
(MedPage Today) — Bioengineered tissue produced with a 3D printer could offer a reconstruction solution that “allows a woman to be whole again” after breast cancer surgery. (CNN)
Aging in fast forward: A husband-caregiver documents his wife’s…
Synergizing global clinical trials data: GLP-1 receptor agonist safety and novel clinical applicationsSynergizing global clinical trials data: GLP-1 receptor agonist safety and novel clinical applications
A research team led by the Department of Medicine, under the School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has synergized the impacts of worldwide clinical trial data through a series of meta-analyses on GLP‑1 receptor agonists, an emerging cardiometabolic drug, offering in-depth insights into its safety profile Read More
New tool spots early signs of infection after breast cancer reconstructionNew tool spots early signs of infection after breast cancer reconstruction
In the U.S., one in eight women will get breast cancer in their lifetime, and about half of them will have mastectomies. Many of those women opt to have their breasts surgically reconstructed, most commonly with implants, but a relatively high percentage develop infections after implant surgery, requiring intravenous antibiotics and often removal of the implant. This can lead to additional surgeries, delays in cancer care and increased costs, as well as added emotional distress for women already under strain from cancer diagnosis and treatment.
‘Sticky coat’ boosts triple negative breast cancer’s ability to metastasize’Sticky coat’ boosts triple negative breast cancer’s ability to metastasize
Researchers at Baylor College of Medicine have uncovered a strategy that triple negative breast cancer (TNBC) cells use to boost their ability to metastasize, or spread to other organs. Metastasis is the leading cause of cancer-related deaths and scientists are investigating ways to prevent it.
Use of GLP-1 Drugs Under Scrutiny at Winter OlympicsUse of GLP-1 Drugs Under Scrutiny at Winter Olympics
(MedPage Today) — As the Winter Olympic Games get underway, the World Anti-Doping Agency (WADA) is monitoring an unexpected class of drugs: GLP-1 receptor agonists. An advisory group that makes recommendations about WADA’s list of prohibited… (MedPage Today) — As the Winter Olympic Games get underway, the World Anti-Doping Agency (WADA) is monitoring an Read More
STAT+: Pharmalittle: We’re reading about TrumpRx, Hims & Hers selling compounded Wegovy pill, and moreSTAT+: Pharmalittle: We’re reading about TrumpRx, Hims & Hers selling compounded Wegovy pill, and more
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, so far, appears rather modest, given the frigid conditions awaiting us. We expect to catch up on our reading, check in on one Read More
STAT+: IPOs, GLP-1s, and challenges with a gene therapySTAT+: IPOs, GLP-1s, and challenges with a gene therapy
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve made it to the end of what’s felt like an extremely long week. Wishing you all a restful weekend and lots of Super Bowl dips. Roivant’s immune drug helped treat rare Read More
Why some breast cancers evade treatment: Protein secreted by T cells may explain resistant tumorsWhy some breast cancers evade treatment: Protein secreted by T cells may explain resistant tumors
Up to 20% of hormone receptor-positive breast cancers don’t respond to antiestrogen therapies. A study led by researchers at UT Southwestern, published in the Journal of Clinical Investigation, suggests that a protein secreted by immune cells within these tumors causes them to grow even in the absence of estrogen.